High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study.
Erwin GarciaMaryse C J OstéDennis W BennettElias J JeyarajahIrina ShalaurovaEke G GruppenStanley L HazenJames D OtvosStephan J L BakkerRobin P F DullaartMargery A ConnellyPublished in: Journal of clinical medicine (2019)
The newly developed NMR-based betaine assay exhibits performance characteristics that are consistent with usage in the clinical laboratory. Betaine levels may be useful for assessing the risk of future T2DM.